127356-27-8

Basic information

• Product Name: 3,4-Pyridinediamine,5-methoxy-(9CI)
• Synonyms: 3,4-Pyridinediamine,5-methoxy-(9CI);3,4-Diamino-5-methoxypyridine;5-Methoxypyridine-3,4-diamine;5-Methoxypyridin-3,4-diaMine
• CAS NO: 127356-27-8
• Molecular Formula: C₆H₉N₃O
• Molecular Weight: 139.157
• Product Categories: PYRIDINE
• Mol File: 127356-27-8.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 383.0±37.0 °C(Predicted)
• Appearance: /
• Density: 1.251±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 9.13±0.10(Predicted)
• CAS DataBase Reference: 3,4-Pyridinediamine,5-methoxy-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-Pyridinediamine,5-methoxy-(9CI)(127356-27-8)
• EPA Substance Registry System: 3,4-Pyridinediamine,5-methoxy-(9CI)(127356-27-8)

Safety Data

• Hazardous Substances Data: 127356-27-8(Hazardous Substances Data)

Usage

General Description

3,4-Pyridinediamine,5-methoxy-(9CI) is a specific type of organic compound categorized under the family of diamines. As per its chemical formula, this compound consists of a pyridine ring with two amine groups (-NH2) on the third and fourth carbon and a methoxy group (-OCH3) on the fifth carbon. It's largely used in various chemical reactions due to its reactivity and structural nature. Despite its specific applications, information regarding its potential hazards or safety measures are not clearly expressed, thus, it's paramount to handle it appropriately, implying standard procedures generally applied for other similar chemical compounds.

Upstream product

• 127356-39-2 4-amino-3-methoxy-5-nitropyridine 
• 52334-90-4 4-amino-3-methoxy pyridine 
• 19355-04-5 3-methoxy-4-nitropyridine 1-oxide 

Downstream Products

• 127356-31-4 7-Methoxy-2-(2-methoxy-4-methylsulfanyl-phenyl)-1H-imidazo[4,5-c]pyridine 
• 127356-09-6 2-(4-Methanesulfinyl-2-methoxy-phenyl)-7-methoxy-1H-imidazo[4,5-c]pyridine 

Relevant articles and documents

Polycyclic compound for inhibiting RNA helicase DHX33

The invention relates to a polycyclic compound for inhibiting RNA helicase DHX33. In particular, the invention relates to a compound shown as a formula I or a pharmaceutically acceptable form thereof, a pharmaceutical composition containing the compound, a preparation method of the compound, and medical application of the compound to prevention and/or treatment of DHX33 related diseases.

Diaminopyridine compounds and methods of use

The present invention relates to compositions and method for inhibiting nonenzymatic cross-linking (protein aging) which contain diaminopyridines and derivates thereof. Accordingly, a composition is disclosed which comprises an agent capable of inhibiting the formation of advanced glycosylation endproducts of target proteins by reacting with the carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.